🇺🇸 FDA
Patent

US 6022854

Platelet specific therapeutic compound and method of treating

expired A61KA61K38/00A61K47/6415

Quick answer

US patent 6022854 (Platelet specific therapeutic compound and method of treating) held by The Regents of the University of California expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/00, A61K47/6415